slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 60,811-60,840
Pages 3,679
Rows per page 30
Component
60,811-60,840 of 110,355
06
The diagram uses a circular flow representing 'Ignore axis' and 'Defend axis' strategies in cancer treatment.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
07
The slide summarizes clinical trial presentation activity at a specific medical conference.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
08
Includes scatter plot (A) and box plot (B) for T-cell proliferation data, plus summary statistics for biliary tract cancer trial.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a standard clinical trial flow diagram (randomization process).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
12
Includes landmark survival rates at 12, 18, and 24 months and time-dependent hazard ratios.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Includes a table of hazard ratios and p-values, and a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
14
Includes Kaplan-Meier plot for DoR and summary tables for ORR and DoR metrics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide uses a dark blue callout box to emphasize the final conclusion/takeaway.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
The slide uses a standard clinical trial flow diagram (CONSORT-style).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
21
Includes a landmark analysis at 9 months for hazard ratios.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Clinical trial data presentation showing PFS, HR, and TTP metrics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The table displays both 'All grades' and 'Grade ≥3' adverse events for specific medical conditions.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
27
Uses a before-after framing to contrast the status quo (problem) with the new clinical solution.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
28
The slide uses a three-column layout to contrast the unmet need, the treatment mechanism, and the clinical outcomes.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
30
The chart uses a bar chart for existing presence and a stacked bar for GI cancer segments.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
36
The chart displays hazard ratios with 95% confidence intervals for different demographic and clinical categories.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The plot visualizes subgroup analysis for a clinical trial, indicating treatment efficacy across different patient demographics and clinical characteristics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations 1 hit
05
Includes a highlighted row for RL-007 and a section for equity interests.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
09
ATAI | Investor Day Presentation Deck | 42 slidesATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
10
The slide uses icons to represent three key negative outcomes for the patient population.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
The slide uses a citation to support the data.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
Data source: Keefe et al, Schiz Res, 2011.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
13
The slide uses a causal chain diagram to link neurocognitive deficits to functional outcomes and a bar chart to show correlation strength.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
The chart uses a broken y-axis between 35 and 100 to accommodate the data distribution.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
15
The slide uses a comparative analysis between cancer and schizophrenia/CIAS to highlight resource allocation disparities.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Agitate (Make it worse)1 hit
30
Includes EEG brain mapping, cognitive test results (Continuity of Attention, Delayed Word Recall), and DPNP study data.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
34
The table uses directional arrows to indicate the direction of change in qEEG endpoints across different cohorts and brain regions (F, C, T, P, O).ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
38
CIAS stands for Cognitive Impairment Associated with Schizophrenia.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
04
The slide uses a combination of bar charts and CAGR metrics to establish a growth benchmark.Babylon | Investor Conference Presentation Deck | 15 slides · Babylon
Conference presentation Investor relations 1 hit